Overview

Hydroxychloroquine in COVID-19 Patients

Status:
Recruiting

Trial end date:
2020-08-01

Target enrollment:

Participant gender:

Summary

Many reports argued about the possible beneficial effects of Hydroxychloroquine in treating COVID-19 patients and this study was designed to investigate this claim

Phase:

Phase 2

Details

Lead Sponsor:

Samah Lutfy

Treatments:

Hydroxychloroquine